News Image

Multiple Studies Highlighting OGM Utility For Analysis of Cancer Biomarker Chromoanagenesis Published in Dedicated Issue of Methods in Molecular Biology

Provided By GlobeNewswire

Last update: Sep 16, 2025

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that an issue of the book series Methods in Molecular Biology dedicated to studies of the catastrophic genome rearrangement known as chromoanagenesis was published with multiple studies highlighting the advantages of optical genome mapping (OGM) in chromoanagenesis research.

Read more at globenewswire.com

BIONANO GENOMICS INC

NASDAQ:BNGO (12/16/2025, 8:01:25 PM)

1.57

+0.03 (+1.95%)



Find more stocks in the Stock Screener

Follow ChartMill for more